The global demand for DNA Bowel Cancer Screening Kits Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2019 with a CAGR of XX% under the study period of 2020 - 2026. Whereas with regards to volume, the market was calculated XX Kilo Units in 2019 and foreseen to touch XX Kilo Units by 2026 with a CAGR of XX% during 2020-2026.
DNA screening test kit for bowel cancer is a non-invasive test that detects microscopic amounts of blood in stool and detects specific changes in several genes associated with colon cancer within the cells shed in stool. These changes and small amounts of blood may be the first and sometimes the only signs of precancerous growths. The kit follows very sensitive laboratory methods and detects a very tiny number of changes. Currently, only one company offers a DNA screening kit for bowel cancer.
The rising burden of colorectal cancer will drive the demand for DNA bowel cancer screening kits and new inventions. As per GLOBOCAN 2018 data, colorectal cancer (CRC) is the third most deadly and fourth most commonly diagnosed cancer in the world. Colorectal cancer incidence has been steadily rising worldwide, especially in developing countries. Looking into a steadily increasing burden, companies are searching for early detection screenings. The DNA test is a relatively new approach for bowel or colon cancer screening. In 2014, the FDA approved the first DNA based screening test kits “Cologuard”. However, the implementation of this kit would not fulfill the cost-effectiveness requirement for clinical use. Hence, in an attempt to reduce the prevalence of colorectal cancer with cost-effective early detection, companies are studying new technologies to commercialize new kits. Favorable results are likely to maximize and benefits market.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of DNA bowel cancer screening kits.
The entire DNA bowel cancer screening kits market has been sub-categorized into application. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
- Diagnostic Laboratories
This section covers regional segmentation which accentuates on current and future demand for DNA bowel cancer screening kits market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Europe DNA Bowel Cancer Screening Kits Market By Revenue (USD MN)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the DNA bowel cancer screening kits market include Exact Sciences Corp. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.